🇮🇳IN
Sign In
PA

PANACEABIO

NSE

Panacea Biotec Limited

₹334.75

+6.65(+2.03%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

PANACEABIO financial summary

For Mar 2026, Panacea Biotec Limited reported revenue of ₹413 crore, which grew 33.2% from the previous year. Net profit was -₹30 crore, on an operating margin of -4%. Earnings per share came in at -₹4.88. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.

Revenue₹413 crore
Net profit-₹30 crore
Operating margin-4%
EPS-₹4.88

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer